Literature DB >> 15386409

Localization of tissue inhibitor of metalloproteinases 1 (TIMP-1) in human colorectal adenoma and adenocarcinoma.

Mads N Holten-Andersen1, Ulla Hansen, Nils Brünner, Hans Jørgen Nielsen, Martin Illemann, Boye Schnack Nielsen.   

Abstract

Tissue inhibitor of matrix metalloproteases 1 (TIMP-1) inhibits the proteolytic activity of matrix metalloproteases and hereby prevents cancer invasion. However, TIMP-1 also possesses other functions such as inhibition of apoptosis, induction of malignant transformation and stimulation of cell-growth. We have previously demonstrated that TIMP-1 is elevated in blood from colorectal cancer patients and that high TIMP-1 levels predict poor prognosis. To clarify the role of TIMP-1 in colorectal tumorigenesis, the expression pattern of TIMP-1 in benign and malignant colorectal tumors was studied. In all of 24 cases of colorectal adenocarcinoma TIMP-1 mRNA was detected by in situ hybridization. In all cases TIMP-1 expression was found in fibroblast-like cells located at the invasive front but was seen only sporadically in normal mucosa. No TIMP-1 mRNA was seen in any of the cases in benign or malignant epithelial cells, in vascular cells or smooth muscle cells. Comparison of sections processed for TIMP-1 in situ hybridization with sections immunohistochemically stained with antibodies against TIMP-1 showed good correlation between TIMP-1 mRNA and immunoreactivity. Combining TIMP-1 in situ hybridization with immunohistochemical staining for alpha-smooth muscle actin or CD68 showed TIMP-1 mRNA in myofibroblasts but not in macrophages. TIMP-1 mRNA was detected in 2 of 7 adenomatous polyps in the adenoma area: in both cases associated with focal stromal inflammation at the epithelial-stromal interface. In conclusion, TIMP-1 expression is a rare event in benign human colon tissue but is highly expressed by myofibroblasts in association with invading colon cancer cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15386409     DOI: 10.1002/ijc.20566

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  15 in total

1.  Characterization of anti-TIMP-1 monoclonal antibodies for immunohistochemical localization in formalin-fixed, paraffin-embedded tissue.

Authors:  Irene Vejgaard Sorensen; Claus Fenger; Henrik Winther; Niels T Foged; Ulrik Lademann; Nils Brünner; Pernille A Usher
Journal:  J Histochem Cytochem       Date:  2006-03-03       Impact factor: 2.479

2.  Liver acid sphingomyelinase inhibits growth of metastatic colon cancer.

Authors:  Yosuke Osawa; Atsushi Suetsugu; Rie Matsushima-Nishiwaki; Ichiro Yasuda; Toshiji Saibara; Hisataka Moriwaki; Mitsuru Seishima; Osamu Kozawa
Journal:  J Clin Invest       Date:  2013-01-09       Impact factor: 14.808

3.  Tissue inhibitor of metalloproteinases (TIMP)-1 creates a premetastatic niche in the liver through SDF-1/CXCR4-dependent neutrophil recruitment in mice.

Authors:  Bastian Seubert; Barbara Grünwald; Julia Kobuch; Haissi Cui; Florian Schelter; Susanne Schaten; Jens T Siveke; Ngee H Lim; Hideaki Nagase; Nicole Simonavicius; Mathias Heikenwalder; Thomas Reinheckel; Jonathan P Sleeman; Klaus-Peter Janssen; Percy A Knolle; Achim Krüger
Journal:  Hepatology       Date:  2014-11-24       Impact factor: 17.425

Review 4.  Tumour-microenvironment interactions: role of tumour stroma and proteins produced by cancer-associated fibroblasts in chemotherapy response.

Authors:  Matthew David Hale; Jeremy David Hayden; Heike Irmgard Grabsch
Journal:  Cell Oncol (Dordr)       Date:  2013-03-14       Impact factor: 6.730

5.  High levels of microRNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patients.

Authors:  Boye Schnack Nielsen; Stine Jørgensen; Jacob Ulrik Fog; Rolf Søkilde; Ib Jarle Christensen; Ulla Hansen; Nils Brünner; Adam Baker; Søren Møller; Hans Jørgen Nielsen
Journal:  Clin Exp Metastasis       Date:  2010-10-31       Impact factor: 5.150

6.  TIMP-1 expression in human colorectal cancer is associated with TGF-B1, LOXL2, INHBA1, TNF-AIP6 and TIMP-2 transcript profiles.

Authors:  Hanne Offenberg; Nils Brünner; Francisco Mansilla; F Orntoft Torben; Karin Birkenkamp-Demtroder
Journal:  Mol Oncol       Date:  2008-06-18       Impact factor: 6.603

7.  Identification of alternatively spliced TIMP-1 mRNA in cancer cell lines and colon cancer tissue.

Authors:  P A Usher; A M Sieuwerts; A Bartels; U Lademann; H J Nielsen; L Holten-Andersen; J A Foekens; N Brünner; H Offenberg
Journal:  Mol Oncol       Date:  2007-05-21       Impact factor: 6.603

8.  Low expression of tissue inhibitor of metalloproteinases-1 (TIMP-1) in glioblastoma predicts longer patient survival.

Authors:  Charlotte Aaberg-Jessen; Karina Christensen; Hanne Offenberg; Annette Bartels; Tanja Dreehsen; Steinbjørn Hansen; Henrik Daa Schrøder; Nils Brünner; Bjarne Winther Kristensen
Journal:  J Neurooncol       Date:  2009-05-09       Impact factor: 4.130

9.  Tissue Inhibitor of Metalloproteinase-1 Is Confined to Tumor-Associated Myofibroblasts and Is Increased With Progression in Gastric Adenocarcinoma.

Authors:  Warner Alpízar-Alpízar; Ole Didrik Laerum; Ib J Christensen; Kjell Ovrebo; Arne Skarstein; Gunilla Høyer-Hansen; Michael Ploug; Martin Illemann
Journal:  J Histochem Cytochem       Date:  2016-07-01       Impact factor: 2.479

10.  Clinical utility of measuring expression levels of KAP1, TIMP1 and STC2 in peripheral blood of patients with gastric cancer.

Authors:  Yuan-Yu Wang; Li Li; Zhong-Sheng Zhao; Hui-Ju Wang
Journal:  World J Surg Oncol       Date:  2013-04-02       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.